DNA: the balance sheet

MyFinsight

For the year ending 2025-12-31, DNA has $1,119,696K in assets. $611,106K in debts. $167,202K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	167,202
Marketable securities	255,418
Accounts receivable, net	24,026
Accounts receivable - related parties	229
Prepaid expenses and other current assets	24,963
Total current assets	471,838
Property, plant and equipment, net	167,783
Operating lease right-of-use assets	360,918
Investments	15,066
Intangible assets, net	56,924
Other non-current assets	47,167
Total assets	1,119,696

Accounts payable	10,566
Deferred revenue (includes 98 and 795 from related parties)	18,946
Accrued expenses and other current liabilities	66,458
Total current liabilities	95,970
Deferred revenue, net of current portion (includes 64,787 and 72,260 from related parties)	75,182
Operating lease liabilities, non-current	417,078
Other non-current liabilities	22,876
Total liabilities	611,106
Common stock, 0.0001 par value (note 13)	6
Additional paid-in capital	6,657,053
Accumulated deficit	-6,150,320
Accumulated other comprehensive income (loss)	1,851
Total stockholders equity	508,590
Total liabilities and stockholders equity	1,119,696

Unit: Thousand (K) dollars (except for numbers of shares and EPS).